Year |
Citation |
Score |
2022 |
MacKenzie JL, Ivanova N, Nell HJ, Giordano CR, Terlecky SR, Agca C, Agca Y, Walton PA, Whitehead SN, Cechetto DF. Microglial Inflammation and Cognitive Dysfunction in Comorbid Rat Models of Striatal Ischemic Stroke and Alzheimer's Disease: Effects of Antioxidant Catalase-SKL on Behavioral and Cellular Pathology. Neuroscience. PMID 35124164 DOI: 10.1016/j.neuroscience.2022.01.026 |
0.742 |
|
2017 |
Bao B, Mitrea C, Wijesinghe P, Marchetti L, Girsch E, Farr RL, Boerner JL, Mohammad R, Dyson G, Terlecky SR, Bollig-Fischer A. Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity. Scientific Reports. 7: 44125. PMID 28281569 DOI: 10.1038/Srep44125 |
0.328 |
|
2016 |
Nell HJ, Au JL, Giordano CR, Terlecky SR, Walton PA, Whitehead SN, Cechetto DF. The targeted antioxidant, catalase-SKL, reduces beta-amyloid toxicity in the rat brain. Brain Pathology (Zurich, Switzerland). PMID 26919450 DOI: 10.1111/Bpa.12368 |
0.75 |
|
2016 |
Farr RL, Lismont C, Terlecky SR, Fransen M. Peroxisome biogenesis in mammalian cells: The impact of genes and environment. Biochimica Et Biophysica Acta. 1863: 1049-60. PMID 26305119 DOI: 10.1016/J.Bbamcr.2015.08.011 |
0.399 |
|
2015 |
Giordano CR, Roberts R, Krentz KA, Bissig D, Talreja D, Kumar A, Terlecky SR, Berkowitz BA. Catalase therapy corrects oxidative stress-induced pathophysiology in incipient diabetic retinopathy. Investigative Ophthalmology & Visual Science. 56: 3095-102. PMID 25813998 DOI: 10.1167/Iovs.14-16194 |
0.745 |
|
2014 |
Giordano CR, Terlecky LJ, Bollig-Fischer A, Walton PA, Terlecky SR. Amyloid-beta neuroprotection mediated by a targeted antioxidant. Scientific Reports. 4: 4983. PMID 24828380 DOI: 10.1038/Srep04983 |
0.775 |
|
2012 |
Giordano CR, Mueller KL, Terlecky LJ, Krentz KA, Bollig-Fischer A, Terlecky SR, Boerner JL. A targeted enzyme approach to sensitization of tyrosine kinase inhibitor-resistant breast cancer cells. Experimental Cell Research. 318: 2014-21. PMID 22687878 DOI: 10.1016/J.Yexcr.2012.06.001 |
0.743 |
|
2012 |
Terlecky SR, Terlecky LJ, Giordano CR. Peroxisomes, oxidative stress, and inflammation. World Journal of Biological Chemistry. 3: 93-7. PMID 22649571 DOI: 10.4331/Wjbc.V3.I5.93 |
0.783 |
|
2012 |
Giordano CR, Terlecky SR. Peroxisomes, cell senescence, and rates of aging. Biochimica Et Biophysica Acta. 1822: 1358-62. PMID 22497955 DOI: 10.1016/J.Bbadis.2012.03.013 |
0.766 |
|
2011 |
Ivashchenko O, Van Veldhoven PP, Brees C, Ho YS, Terlecky SR, Fransen M. Intraperoxisomal redox balance in mammalian cells: oxidative stress and interorganellar cross-talk. Molecular Biology of the Cell. 22: 1440-51. PMID 21372177 DOI: 10.1091/Mbc.E10-11-0919 |
0.492 |
|
2011 |
Titorenko VI, Terlecky SR. Peroxisome metabolism and cellular aging. Traffic (Copenhagen, Denmark). 12: 252-9. PMID 21083858 DOI: 10.1111/J.1600-0854.2010.01144.X |
0.451 |
|
2011 |
Undyala V, Terlecky SR, Vander Heide RS. Targeted intracellular catalase delivery protects neonatal rat myocytes from hypoxia-reoxygenation and ischemia-reperfusion injury. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 20: 272-80. PMID 20708413 DOI: 10.1016/J.Carpath.2010.06.011 |
0.337 |
|
2009 |
Zhong Q, Terlecky SR, Lash LH. Diabetes increases susceptibility of primary cultures of rat proximal tubular cells to chemically induced injury. Toxicology and Applied Pharmacology. 241: 1-13. PMID 19682476 DOI: 10.1016/J.Taap.2009.08.007 |
0.339 |
|
2009 |
Price M, Terlecky SR, Kessel D. A role for hydrogen peroxide in the pro-apoptotic effects of photodynamic therapy. Photochemistry and Photobiology. 85: 1491-6. PMID 19659920 DOI: 10.1111/J.1751-1097.2009.00589.X |
0.426 |
|
2008 |
Koepke JI, Wood CS, Terlecky LJ, Walton PA, Terlecky SR. Progeric effects of catalase inactivation in human cells. Toxicology and Applied Pharmacology. 232: 99-108. PMID 18634817 DOI: 10.1016/J.Taap.2008.06.004 |
0.808 |
|
2008 |
Young CN, Koepke JI, Terlecky LJ, Borkin MS, Boyd SL, Terlecky SR. Reactive oxygen species in tumor necrosis factor-α-activated primary human keratinocytes: Implications for psoriasis and inflammatory skin disease Journal of Investigative Dermatology. 128: 2606-2614. PMID 18463678 DOI: 10.1038/Jid.2008.122 |
0.749 |
|
2007 |
Koepke JI, Nakrieko KA, Wood CS, Boucher KK, Terlecky LJ, Walton PA, Terlecky SR. Restoration of peroxisomal catalase import in a model of human cellular aging. Traffic (Copenhagen, Denmark). 8: 1590-600. PMID 17822396 DOI: 10.1111/J.1600-0854.2007.00633.X |
0.809 |
|
2007 |
Terlecky SR, Koepke JI. Drug delivery to peroxisomes: employing unique trafficking mechanisms to target protein therapeutics. Advanced Drug Delivery Reviews. 59: 739-47. PMID 17659806 DOI: 10.1016/J.Addr.2007.06.005 |
0.796 |
|
2006 |
Terlecky SR, Koepke JI, Walton PA. Peroxisomes and aging. Biochimica Et Biophysica Acta. 1763: 1749-54. PMID 17027095 DOI: 10.1016/J.Bbamcr.2006.08.017 |
0.804 |
|
2006 |
Wood CS, Koepke JI, Teng H, Boucher KK, Katz S, Chang P, Terlecky LJ, Papanayotou I, Walton PA, Terlecky SR. Hypocatalasemic fibroblasts accumulate hydrogen peroxide and display age-associated pathologies. Traffic (Copenhagen, Denmark). 7: 97-107. PMID 16445690 DOI: 10.1111/J.1600-0854.2005.00358.X |
0.801 |
|
2004 |
Logsdon BC, Vickrey JF, Martin P, Proteasa G, Koepke JI, Terlecky SR, Wawrzak Z, Winters MA, Merigan TC, Kovari LC. Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity. Journal of Virology. 78: 3123-32. PMID 14990731 DOI: 10.1128/Jvi.78.6.3123-3132.2004 |
0.732 |
|
2003 |
Brocard CB, Jedeszko C, Song HC, Terlecky SR, Walton PA. Protein structure and import into the peroxisomal matrix. Traffic (Copenhagen, Denmark). 4: 74-82. PMID 12559034 DOI: 10.1034/J.1600-0854.2003.40203.X |
0.347 |
|
2002 |
Terlecky SR. In vitro analysis of peroxisomal protein import. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. Unit 11.15. PMID 18228397 DOI: 10.1002/0471143030.Cb1115S14 |
0.401 |
|
2002 |
Legakis JE, Koepke JI, Jedeszko C, Barlaskar F, Terlecky LJ, Edwards HJ, Walton PA, Terlecky SR. Peroxisome senescence in human fibroblasts. Molecular Biology of the Cell. 13: 4243-55. PMID 12475949 DOI: 10.1091/Mbc.E02-06-0322 |
0.764 |
|
2001 |
Legakis JE, Terlecky SR. PTS2 protein import into mammalian peroxisomes. Traffic (Copenhagen, Denmark). 2: 252-60. PMID 11285135 DOI: 10.1046/J.1398-9219.2001.00009.X |
0.76 |
|
2001 |
Terlecky SR, Fransen M. How peroxisomes arise. Traffic (Copenhagen, Denmark). 1: 465-73. PMID 11208132 DOI: 10.1034/J.1600-0854.2000.010604.X |
0.333 |
|
2001 |
Terlecky SR, Legakis JE, Hueni SE, Subramani S. Quantitative analysis of peroxisomal protein import in vitro. Experimental Cell Research. 263: 98-106. PMID 11161709 DOI: 10.1006/Excr.2000.5111 |
0.764 |
|
1994 |
Dice JF, Agarraberes F, Kirven-Brooks M, Terlecky LJ, Terlecky SR. 6 Heat Shock 70-kD Proteins and Lysosomal Proteolysis Cold Spring Harbor Monograph Archive. 26: 137-151. DOI: 10.1101/087969427.26.137 |
0.311 |
|
Show low-probability matches. |